JHMD - ETF AI Analysis
Top Page
John Hancock Multifactor Developed International ETF (JHMD)
Rating:64Neutral
Price Target:―
Positive Factors
Broad Country Diversification
The fund spreads its investments across many developed markets like Japan, the UK, Germany, and others, which helps reduce the impact of problems in any single country.
Generally Strong Top Holdings
Most of the largest positions, including companies like ASML, BP, and Vinci, have shown strong recent performance, which supports the ETF’s overall returns.
Solid Recent Performance
The ETF has delivered steady gains over the past month, three months, and year-to-date, suggesting its strategy has been working in the current market.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially low for an ETF, which slightly reduces the net return investors keep over time.
Financial Sector Exposure
A meaningful allocation to financial stocks can make the fund more sensitive to changes in interest rates and banking conditions.
Some Lagging Holdings
At least one top holding, such as BBVA, has shown weak recent performance, which can drag on the fund if that trend continues.
JHMD vs. SPDR S&P 500 ETF (SPY)
AUM942.98M
RegionDeveloped Markets
Expense Ratio0.39%
Beta0.69
IssuerJohn Hancock
Inception DateDec 15, 2016
Dividend Yield2.94%
Asset ClassEquity
Index TrackedJohn Hancock Dimensional Developed International Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume101,841
30 Day Avg. Volume115,706
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
51.01Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering571
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JHMD Summary
JHMD is the John Hancock Multifactor Developed International ETF, which follows the John Hancock Dimensional Developed International Index. It invests in a wide range of companies from developed countries like Japan, the UK, and Germany across many sectors. Well-known holdings include ASML Holding and AstraZeneca. Investors might consider this ETF to diversify beyond the U.S. and spread their money across many international stocks for long-term growth. A key risk is that international stock prices can go up and down with global markets and currency swings, so the value of this ETF can be volatile.
How much will it cost me?The John Hancock Multifactor Developed International ETF (JHMD) has an expense ratio of 0.39%, which means you’ll pay $3.90 per year for every $1,000 invested. This cost is slightly higher than average for passively managed ETFs because it uses a multifactor strategy to optimize risk and reward across developed international markets.
What would affect this ETF?Positive drivers for JHMD include potential economic growth in developed international markets outside North America, which could boost the performance of its top holdings like Vinci SA and Novartis AG. However, negative factors such as rising interest rates or economic slowdowns in Europe could impact sectors like Financials and Industrials, which make up a significant portion of the ETF's exposure.
JHMD Top 10 Holdings
JHMD’s story is all about broad developed-markets exposure with a noticeable tilt toward Europe, where industrials, financials, and health care names set the tone. ASML has been a key engine, riding the global chip boom, while Vinci and BASF add steady industrial strength with recently rising share prices. On the financial side, HSBC is helping, but BBVA has been more mixed, occasionally losing steam. In health care, Novartis and AstraZeneca provide a calmer, defensive backbone, and BP’s strong run in energy adds extra fuel to this internationally focused portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.76% | $17.06M | €503.99B | 110.43% | 76 Outperform | |
| Vinci SA | 1.73% | $16.80M | €71.89B | 2.54% | 76 Outperform | |
| BASF SE | 1.04% | $10.08M | €46.10B | 18.97% | 61 Neutral | |
| Engie SA | 1.00% | $9.75M | €68.25B | 48.87% | 64 Neutral | |
| HSBC Holdings | 0.96% | $9.33M | £226.79B | 55.42% | 80 Outperform | |
| Banco Bilbao Vizcaya Argentaria | 0.96% | $9.28M | €106.35B | 56.00% | 76 Outperform | |
| SoftBank Group | 0.82% | $7.93M | ¥35.00T | 230.21% | 64 Neutral | |
| Novartis AG | 0.79% | $7.67M | CHF206.95B | 24.69% | 80 Outperform | |
| Bayer | 0.76% | $7.34M | €36.33B | 55.57% | 54 Neutral | |
| ORANGE SA | 0.75% | $7.29M | €47.41B | 40.87% | 65 Neutral |
JHMD Technical Analysis
Positive
―
Price Trends
43.48
Positive
43.37
Positive
41.37
Positive
Market Momentum
0.30
Negative
57.15
Neutral
82.62
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JHMD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 44.48, equal to the 50-day MA of 43.48, and equal to the 200-day MA of 41.37, indicating a bullish trend. The MACD of 0.30 indicates Negative momentum. The RSI at 57.15 is Neutral, neither overbought nor oversold. The STOCH value of 82.62 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JHMD.
JHMD Peer Comparison
Comparison Results
Performance Comparison
JHMD
John Hancock Multifactor Developed International ETF
45.06
9.47
26.61%
IQDG
WisdomTree International Quality Dividend Growth Fund
―
―
―
NUDM
Nuveen ESG International Developed Markets Equity ETF
―
―
―
DWM
WisdomTree International Equity Fund
―
―
―
EFAX
SPDR MSCI EAFE Fossil Fuel Free ETF
―
―
―
JPIN
J.P. Morgan Diversified Return International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents